Ho Chi Minh City Medial Import Export Joint Stock Co
UUPCOM:YTC21,000.00
VND
-700.00
(-3.23%)
ISIN
VN000000YTC0
Return %
Stock
S&P 500
1Y
-40.68
14.20
3Y
-60.60
81.12
5Y
-65.06
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- Address
- IPO Date
- Aug 3, 2017
- Similar Companies
- Business
- Ho Chi Minh City Medical Import Export Joint Stock Company (YTECO) is a Vietnam-based healthcare supply chain and distribution enterprise specializing in the import, export, wholesale, and retail distribution of pharmaceuticals, active pharmaceutical ingredients, medical devices, and healthcare products. Established in 1984 and headquartered in Ho Chi Minh City, Vietnam, the company operates across the healthcare, biotechnology, and medical logistics sectors, serving public and private hospitals, specialized clinics, research institutions, healthcare centers, retail pharmacy chains, and commercial distribution partners nationwide. The company operates through three principal business segments: Pharmaceutical Distribution, Medical Equipment and Healthcare Supplies, and Healthcare Logistics and Warehousing Services. Its core product and service portfolio comprises the importation, registration, marketing, and distribution of finished prescription medicines and over-the-counter pharmaceuticals spanning cardiovascular, oncology, anti-infective, gastrointestinal, respiratory, and central nervous system therapeutics; active pharmaceutical ingredients (APIs), intermediate chemicals, and pharmaceutical excipients for domestic medicine manufacturing; diagnostic imaging systems, surgical instruments, patient monitoring equipment, laboratory diagnostic reagents, and specialized electromedical devices; disposable medical supplies, wound care products, and personal protective equipment; vaccines, biological products, blood derivatives, and nutritional supplements; and supply chain management services comprising Good Storage Practice (GSP) and Good Distribution Practice (GDP) certified warehousing, temperature-controlled cold chain logistics, bonded storage, customs clearance, regulatory filing, and nationwide pharmaceutical freight forwarding. In recent operational developments, Ho Chi Minh City Medical Import Export Joint Stock Company has expanded its cold-chain infrastructure and modernized its central logistics hubs with automated warehouse management systems to meet international compliance standards for specialized biologics and temperature-sensitive specialty therapeutics. The company has broadened its commercial partnerships by securing exclusive and direct distribution agreements with multinational pharmaceutical and medical device manufacturers across Europe, North America, and Asia-Pacific. Furthermore, the enterprise has accelerated its digital transformation through the deployment of integrated enterprise resource planning and electronic B2B procurement platforms, while expanding its public hospital tender participation and private healthcare supply networks across southern and central Vietnam.